
Tsubota Laboratory Incorporated
4890.TJPXIndustrialsSpecialty Business Services
Latest quote
¥274
−¥3.00 · -1.08%
Aug 24, 11:25 AM JST
4890.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteOperating from Tokyo, Japan since its establishment in 2012, Tsubota Laboratory Incorporated is dedicated to the research and development of pharmaceutical products and medical devices, specifically targeting the treatment of myopia, dry eyes, and presbyopia.
- Industry
- Specialty Business Services
- Sector
- Industrials
- Headquarters
- JP
- CEO
- Kazuo Tsubota
- Listed since
- Jun 23, 2022
- Employees
- 22
Market position
Day range
Current ¥274
¥271¥277
52-week range
Current ¥274
¥210¥478
- Open
- ¥275
- Previous close
- ¥277
- Volume
- 10.2K
- 0.13× average
- Average volume
- 77.79K
- Average daily volume
- Market cap
- 7.07B JPY
- Beta
- 1.15
- Market reference 1
- 50-day average
- ¥243.5
- +12.53% above average
- 200-day average
- ¥296.62
- -7.62% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 6.67B JPY
- P/E (TTM)
- -10.19×
- P/B (TTM)
- 9.63×
- P/S (TTM)
- 18.1×
- EV / EBITDA
- -8.72×
- Earnings yield
- -10.06%
- Free cash flow yield
- -7.75%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 37.96%
- Operating margin
- -189.27%
- Net margin
- -177.59%
- Return on equity
- -88.19%
- Return on assets
- -57.77%
- Return on invested capital
- -84.26%
Financial health
- Debt / equity
- 0.09×
- Current ratio
- 3.14×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Gross marginOperating marginNet margin
Income trends
Revenue
200.02M JPY-85.26%
Operating income
−786.23M JPY−1.02B JPY
Net income
−761.82M JPY−967.58M JPY
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 200.02M JPY | 1.36B JPY | 673.53M JPY | 954.69M JPY | 640.92M JPY |
| Cost of goods sold | 68.45M JPY | 204.54M JPY | 683.02M JPY | 267.86M JPY | 112.16M JPY |
| Gross profit | 131.57M JPY | 1.15B JPY | −9.48M JPY | 686.83M JPY | 528.76M JPY |
| Research and development | — | 254.11M JPY | 205.3M JPY | 126.27M JPY | 116.97M JPY |
| Selling, general, and administrative | 917.8M JPY | 661.43M JPY | 427.23M JPY | 393.54M JPY | 275.62M JPY |
| Operating expenses | 917.8M JPY | 915.54M JPY | 632.52M JPY | 519.8M JPY | 392.59M JPY |
| Interest income | 3.05M JPY | 961K JPY | 18K JPY | 18K JPY | 11K JPY |
| Interest expense | 698K JPY | 1.09M JPY | 1M JPY | 778K JPY | 1.03M JPY |
| Depreciation and amortization | 20.99M JPY | 25.4M JPY | 32.77M JPY | 39.19M JPY | 37.7M JPY |
| Operating income | −786.23M JPY | 237.05M JPY | −642.01M JPY | 167.03M JPY | 136.17M JPY |
| Net income | −761.82M JPY | 205.77M JPY | −641.32M JPY | 90.18M JPY | 153.32M JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- -5.2
EPS: actual versus estimate
Recent quarterly results
ActualEstimate
Estimates unavailableRevenue: actual versus estimate
Recent quarterly results
ActualEstimate
Estimates unavailable4890.T peers
Continue in GoAI
Research 4890.Tresearch.disclaimer





